Furosemide in Acute Pulmonary Edema

Introduction to Furosemide Therapy

• The European Society of Cardiology recommends furosemide be used cautiously in the prehospital setting, primarily as adjunctive therapy combined with high-dose nitrates, with an initial dose of 20-40 mg IV for patients with acute pulmonary edema and systolic blood pressure ≥90-100 mmHg 1, 2

Critical Pre-Administration Requirements

• Systolic blood pressure must be ≥90-100 mmHg before administering furosemide, as it can worsen hypoperfusion and precipitate cardiogenic shock in hypotensive patients 1, 3
• Absence of marked hypovolemia is necessary, assessed by decreased skin turgor, tachycardia, and signs of poor perfusion 1, 3
• Clinical evidence of pulmonary edema, such as rales on chest examination and respiratory distress with SpO2 <90% when sitting upright, is required 2, 4

Evidence-Based Dosing Strategy

• The initial dose of furosemide should be 20-40 mg IV push over 1-2 minutes, with 40 mg IV recommended for new-onset heart failure or patients not on chronic diuretics 1, 5
• For patients on chronic oral furosemide, the IV dose should be at least equivalent to their oral dose 1, 5

Combination Therapy

• The American College of Emergency Physicians and European Society of Cardiology recommend combination therapy with high-dose nitrates and low-dose furosemide, as it significantly outperforms high-dose furosemide with low-dose nitrates 1, 4, 2
• In the Cotter study, the high-dose nitrate + low-dose furosemide group had a 13% intubation rate, compared to 40% in the high-dose furosemide + low-dose nitrate group (P<0.005) 2, 4

Optimal Prehospital Treatment Algorithm

• For acute pulmonary edema with SBP ≥110 mmHg, the European Heart Journal recommends starting IV nitroglycerin immediately and adding furosemide 40 mg IV as adjunctive therapy 1, 3
• For acute pulmonary edema with SBP 90-110 mmHg, furosemide 20-40 mg IV should be administered cautiously, with nitrates used with extreme caution and monitoring of blood pressure every 5-10 minutes 1, 3

Hemodynamic Concerns

• Furosemide causes transient worsening of hemodynamics for 1-2 hours after administration, including increased systemic vascular resistance, left ventricular filling pressures, and decreased stroke volume 2, 4, 6

Renal and Electrolyte Concerns

• Furosemide is associated with worsening renal function, particularly at higher doses, and this is a significant concern as worsening renal function during hospitalization increases mortality nearly 3-fold 2, 4

Evidence Quality and Limitations

• The recommendation for combination therapy is based on one Class III prehospital RCT (Cotter study, N=104) and consensus guidelines from the European Society of Cardiology and American College of Emergency Physicians 1, 4, 2

Transition to Hospital Care

• The European Society of Cardiology recommends communicating the exact dose and time of furosemide administration, pre-treatment blood pressure and response, urine output during transport, and any concurrent medications given to the receiving ED 1